|
06-05-2013 |
Anti-HBV vaccine fails against chronic hepatitis B |
|
06-04-2013 |
Blood tests diagnose fibrosis, cirrhosis in chronic hepatitis C |
|
05-07-2013 |
Antivirals effective against HBV post liver transplant, without HBIG |
|
05-03-2013 |
Early HCV response more likely with peg-interferon alpha-2a than -2b |
|
05-02-2013 |
Combo hepatitis C pill shown effective in small mid-stage trial |
|
04-23-2013 |
Interferon may curb recurrence of liver cancer |
|
04-23-2013 |
Bristol-Myers oral HCV regimen looks competitive in phase II trial |
|
04-23-2013 |
New AbbVie drugs cure hepatitis C at eight weeks |
|
04-08-2013 |
High-intensity focused ultrasound compares favorably with RFA for recurrent hepatoma |
|
03-27-2013 |
Early test of micro-RNA-targeting drug shows promise against HCV |
|
03-19-2013 |
Phlebotomy might help in fatty liver disease |
|
03-15-2013 |
Device keeps liver "alive" outside the body in medical first |
|
03-08-2013 |
Leptin helpful in non-alcoholic steatohepatitis |
|
03-08-2013 |
For adefovir nephrotoxicity, just lower the dose |
|
02-19-2013 |
Sofosbuvir for Hep C drug meets main goal of fourth late-stage study |
|
02-04-2013 |
Two hepatitis C drug trials meet study goals |
|
01-31-2013 |
Experimental liver cancer therapy fails in late-stage trial |
|
12-06-2012 |
Sorafenib can be combined with arterial embolization for treating liver tumors |
|
12-06-2012 |
Early response points to boceprevir combo success in HCV |
|
12-05-2012 |
HCV response to IFN/ribavirin hints at response to telaprevir |
|
11-29-2012 |
Liraglutide safe, effective in type 2 diabetics with liver injury |
|
11-27-2012 |
Hepatitis C drug shows promise in late-stage trial |
|
11-12-2012 |
Boehringer Ingelheim to start late-stage hepatitis C drug trial |
|
11-12-2012 |
Novartis' Certican succeeds in liver transplant trial |
|
11-12-2012 |
Abbott hepatitis C drugs bring high cure rates in trial |
|
10-25-2012 |
Telaprevir, boceprevir offer similar efficacy for most patients with HCV 1 |
|
10-15-2012 |
Rapid and point-of-care tests accurately diagnose hepatitis C |
|
09-27-2012 |
Gemcitabine-oxaliplatin combo effective in advanced liver cancer |
|
09-25-2012 |
Vertex ends work on one hepatitis C drug, continues another |
|
09-03-2012 |
Raloxifene aids HCV therapy in some postmenopausal women |
|
08-01-2012 |
Doxorubicin-eluting beads improve HCC outcomes |
|
07-30-2012 |
High-dose ribavirin plus EPO no extra help against HCV in HIV |
|
07-25-2012 |
Low-dose flutamide doesn't eliminate hepatotoxicity risk |
|
07-16-2012 |
Prophylactic antidepressant may ward off interferon blues |
|
07-13-2012 |
Long-term entecavir effective for chronic HBV |
|
07-11-2012 |
Sorafenib beneficial in liver cancer regardless of etiology |
|
06-07-2012 |
Some rapid hep B screening tests highly accurate |
|
05-31-2012 |
Bristol urges combo study with Gilead hepatitis drug |
|
04-19-2012 |
Dramatic data for Gilead, Bristol hepatitis C drugs |
|
04-19-2012 |
Telaprevir may cause severe cutaneous eruptions |
|
04-11-2012 |
Tremelimumab shows promise in patients with liver cancer |
|
04-04-2012 |
Abbott hepatitis C combo impressive in small study |
|
03-06-2012 |
Vertex, Merck hepatitis drugs work in HIV patients |
|
03-06-2012 |
More patients relapse in Gilead hepatitis C trial |
|
02-24-2012 |
Gilead hepatitis C setback opens door to rivals |
|
02-21-2012 |
Noradrenaline a cost-effective option for type 1 hepatorenal syndrome |
|
02-20-2012 |
Vandetanib shows limited clinical activity in inoperable hepatocellular carcinoma |
|
02-17-2012 |
Some patients in hep C trial show relapse: Gilead |
|
02-14-2012 |
Tyrosine kinase inhibitors linked to increased treatment-related mortality |
|
02-10-2012 |
In small pilot study, some pediatric liver recipients come off immunosuppression |
|
02-08-2012 |
Interferon and ribavirin control HCV genotype 6 |
|
01-18-2012 |
Four-drug therapy wiped out hepatitis C virus in most cases |
|
01-13-2012 |
Rituximab helpful against HCV cryoglobulinemic vasculitis |
|
01-06-2012 |
Adjuvant interferon doesn't prevent HCC recurrence |
|
01-04-2012 |
Experimental hepatitis C vaccine shows early promise |
|
01-03-2012 |
Aveo kidney cancer drug improves survival in late stage |
|
01-02-2012 |
Stem cell preconditioning boosts liver volume before resection |
|
12-29-2011 |
Combination therapy useful for advanced hepatoma |
|
12-27-2011 |
Severe cryoglobulinemic vasculitis responds to rituximab therapy |
|
12-23-2011 |
Bristol-Myers liver cancer drug brivanib fails phase III trial |
|
11-11-2011 |
Pharmasset upbeat on drug for resistant hep C strain: CEO |
|
11-10-2011 |
Stool color cards hasten referrals for biliary atresia |
|
11-07-2011 |
Smallpox vaccine extends life in phase II hepatoma trial |
|
09-29-2011 |
Vertex takes early rounds of hep C bout with Merck |
|
09-07-2011 |
Adding telaprevir improves chronic hepatitis C therapy |
|
09-06-2011 |
Pharmasset hep C drug shows promise in mid-stage trial |
|
08-04-2011 |
Midodrine controls ascites, improves survival in cirrhotic patients |
|
08-03-2011 |
Radiofrequency ablation a good option in early HCC, for some |
|
07-28-2011 |
Perflubutane improves intra-op ultrasound diagnosis of HCC |
|
07-26-2011 |
Vertex says combo hepatitis C treatment works |
|
07-18-2011 |
Pitavastatin may enhance antivirals in some hepatitis C patients |
|
06-03-2011 |
Renal effect of tenofovir is milder when it's used only for HBV |
|
05-25-2011 |
Particle therapy promising in liver cancer |
|
05-19-2011 |
Exelixis drug cabozantinib shown to control solid tumors |
|
05-06-2011 |
Faster hepatitis B vaccine schedule has benefits in pregnancy |
|
05-03-2011 |
Thiazolidinediones minor help in non-alcoholic steatohepatitis |
|
05-02-2011 |
Advantages of stereotactic body radiation therapy remain questionable |
|
04-28-2011 |
Selumetinib fails in HCC trial, minimally better in biliary cancer |
|
04-27-2011 |
Telbivudine during pregnancy safely reduces vertical transmission of HBV |
|
04-20-2011 |
Stereotactic radiotherapy helpful in colorectal liver metastases |
|
04-12-2011 |
More immunogenic HBV vaccine regimens better in HIV-infected patients |
|
04-12-2011 |
Vena cava clamping reduces hepatic resection blood loss |
|
04-08-2011 |
High-intensity ultrasound gets high marks for HCC ablation |
|
03-25-2011 |
Early liver biopsy important in alcoholic cirrhosis |
|
03-15-2011 |
BCAAs won't prevent recurrent hepatic encephalopathy |
|
03-10-2011 |
Low-dose interferon safe, effective for dialysis patients with hepatitis C |
|
03-03-2011 |
Antiviral therapy lowers insulin resistance in HCV genotype 1 infection |
|
02-28-2011 |
Rifaximin improves cognitive function in hepatic encephalopathy |
|
02-24-2011 |
Adding telaprevir shortens HCV treatment for many |
|
02-17-2011 |
Bevacizumab combo "encouraging" for advanced hepatoma |
|
02-16-2011 |
Children with chronic hepatitis C respond well to peginterferon plus ribavirin |
|
02-02-2011 |
Mycophenolate mofetil helps avoid steroids for autoimmune hepatitis |
|
01-28-2011 |
Study finds no evidence black cohosh damages liver |
|
01-26-2011 |
Peginterferon clears hepatitis D virus in nearly one quarter of cases |
|
01-26-2011 |
Ambrisentan promising in portopulmonary hypertension |
|
01-14-2011 |
Sanofi confirms liver damage in 2 Multaq patients |
|
01-06-2011 |
No benefit from adjuvant bevacizumab for colon cancer metastases to liver |
|
12-29-2010 |
Rifaximin improves cognition in minimal hepatic encephalopathy |
|
12-22-2010 |
Cyanoacrylate injection advised for high-risk gastric varices |
|
11-26-2010 |
Novel protease inhibitor active against hepatitis C |
|
10-20-2010 |
Nonalcoholic steatohepatitis improves with pentoxifylline |
|
10-18-2010 |
Roche hepatitis C drug appears safe in combination |
|
09-08-2010 |
Telaprevir achieves SVR in toughest hepatitis C patients |
|
08-23-2010 |
Hepatitis E vaccine appears effective in China trial |
|
08-10-2010 |
Hep C protease inhibitor telaprevir works in 24 weeks: study |
|
08-09-2010 |
Protease inhibitor improves treatment of hepatitis C |
|
08-04-2010 |
Merck hepatitis C drug works; anemia seen |
|
06-10-2010 |
Yttrium-90 radioembolization effective for neuroendocrine liver metastases |
|
06-07-2010 |
Delcath sends melphalan directly into liver via hepatic artery |
|
05-25-2010 |
Telaprevir achieves 75% rate of sustained HCV response: study |
|
05-05-2010 |
Telaprevir improves sustained response rates in refractory HCV |
|
04-29-2010 |
Octreotide shrinks polycystic livers and kidneys |
|
04-21-2010 |
Metastatic melanoma trial meets main goal |
|
04-21-2010 |
New compound potent against hepatitis C |
|
04-16-2010 |
Gilead drug effective against liver disease: study |
|
03-31-2010 |
Pegylated arginine deiminase has potential for unresectable hepatoma |
|
02-24-2010 |
New hepatitis C drug shows good response in early trial |
|
12-24-2009 |
Angiographic subsegmentectomy safe and effective for small liver tumors |
|
12-03-2009 |
Hepatitis C drug fights virus in new way |
|
08-18-2009 |
Sinovac says one-shot swine flu vaccine effective |
|
08-14-2009 |
Glaxo starts testing flu pandemic vaccine |
|
05-14-2009 |
Novel anti-HBV vaccine may prevent hepatocellular carcinoma |
|
04-09-2009 |
AMD11070 shows action against X4-tropic HIV |
|
03-09-2009 |
Human Genome hepatitis C drug disappoints, shares crash |
|
12-25-2008 |
Silibinin infusion has antiviral effect against HCV in nonresponders |
|
11-03-2008 |
Therapeutic hepatitis C vaccine shows benefit in phase 2 trial |
|
08-22-2008 |
Silymarin prevents antituberculosis drug-related hepatotoxicity in rats |
|
06-30-2008 |
Peptide vaccine shows some promise in hard-to-treat HCV |
|
06-03-2008 |
IKK2 inhibition blocks liver steatosis in mice |
|
04-30-2008 |
Radioembolization promising for inoperable chemorefractory liver metastases |
|
12-03-2007 |
Fluoroscopy plus CT allows real-time evaluation of liver shunt placement |
|
10-25-2007 |
Sunitinib shows promise against advanced hepatocellular carcinoma |
|
09-20-2007 |
Hypermethylated DNA in circulation of patients with HBV predicts liver cancer |
|
09-18-2007 |
Immune activator may make interferon-alpha more potent as HCV treatment |
|
09-03-2007 |
Nano-coating of biliary stents prevents clogging |
|
08-01-2007 |
Investigational antitumor agent nolatrexed fails in phase III study of liver cancer |
|
05-15-2007 |
New HCV protease inhibitor effective against hepatitis C |
|
03-27-2007 |
Fractalkine curbs metastatic colon cancer in mice |
|
03-23-2007 |
Nitroflurbiprofen promising for cirrhotic portal hypertension |
|
01-10-2007 |
Investigational agent reduces LDL cholesterol in familial hypercholesterolemia |
|
11-13-2006 |
Radiolabeled antibodies kill HIV-1-infected cells |
|
10-04-2006 |
Cyclophilin inhibitor acts against hepatitis C virus |
|
07-13-2006 |
New blood test detects non-alcoholic steatohepatitis |
|
07-10-2006 |
Statins may hold promise for chronic hepatitis C infection |
|
05-22-2006 |
Hepatitis C protease inhibitor shows "dramatic" antiviral effects |
|
05-01-2006 |
Human Genome says hepatitis C drug worked in combo |
|
03-08-2006 |
Entecavir bests lamivudine for treatment of chronic hepatitis B |
|
02-06-2006 |
Hepatitis C vaccine induces cellular immunity in chimpanzees |
|
01-23-2006 |
Hepatitis C vaccine candidate shows promise in mice |
|
12-05-2005 |
Radiation therapy improves outcome of unresectable hepatic cancer |
|
11-01-2005 |
Entecavir safe, effective in lamivudine-refractory hepatitis B virus |
|
08-29-2005 |
Oral fluid assay detects hepatitis B |
|
05-17-2005 |
Vertex says investigational drug rapidly suppresses hepatitis C virus |
|
05-10-2005 |
Vertex reports positive data for hepatitis C drug |
|
02-14-2005 |
Potato vaccine immunogenic against hepatitis B |
|
01-27-2005 |
Thalidomide of little value for advanced hepatocellular carcinoma |
|
12-15-2004 |
Experimental vaccine effective in animal model of amebiasis |
|
12-09-2004 |
Dynavax hepatitis B vaccine results encouraging in trial |
|
11-15-2004 |
BILN 2061 impressively reduces HCV load but toxicity a concern |
|
09-29-2004 |
New agent shows action against liver tumours |
|
09-27-2004 |
Drug-releasing beads lower complications of chemotherapy in small trial |
|
09-20-2004 |
Investigational drug fails to improve survival in melanoma metastasized to liver |
|
06-29-2004 |
Microscience reports good phase I results with oral hepatitis B vaccine |
|
06-23-2004 |
Plant-derived MAb to HBV surface antigen may provide treatment alternative |
|
06-18-2004 |
Transcutaneous bilirubinometer may obviate most neonatal serum bilirubin tests |
|
05-18-2004 |
Polymerase inhibitor safely reduced HCV viral load in humans: phase I/II trial |
|
04-22-2004 |
Bioartificial liver improves survival in patients with severe hepatic failure |
|
04-16-2004 |
Pegasys eradicates hepatitis B in some patients: Roche |
|
03-25-2004 |
Fibrosis improved with hepatitis C vaccine, Innogenetics reports |
|
03-18-2004 |
Antiretrovirus enzyme works against HBV |
|
03-12-2004 |
Biomarker combination may noninvasively diagnose cirrhosis |
|
03-02-2004 |
Roche says Pegasys can be tailored to hepatitis C genotype |
|
02-10-2004 |
Radiolabeled tumor necrosis therapy shows strong binding in liver procedures |
|
01-09-2004 |
Herbal derivative shown to accelerate bilirubin clearance in mice |
|
12-24-2003 |
Drugs in development hold promise for patients with HIV and HBV coinfection |
|
11-24-2003 |
Cuba produces key synthetic vaccine for children |
|
10-28-2003 |
Roche's Pegasys shown advantageous for treatment of hepatitis B |
|
10-27-2003 |
Hepatitis C protease inhibitor reduces viral load |
|
09-02-2003 |
Risk data on Astra's Exanta deemed reassuring |
|
09-01-2003 |
Assay detects hepatitis C antibody in oral fluids, dried blood spots |
|
05-06-2003 |
Glove containing disinfectant may protect against viral infection |